Drug interaction classified as: absorption
Source: DDInter
Immunosuppressant · Immunosuppressant; Prophylaxis of graft rejection in renal transplantation
Also known as Myfenax, Mycophenolate mofetil hydrochloride
Mycophenolate mofetil is a prodrug that is rapidly hydrolyzed to mycophenolic acid (MPA), a selective, reversible, non-competitive inhibitor of inosine monophosphate dehydrogenase (IMPDH) type II — the rate-limiting enzyme in the de novo pathway of guanosine nucleotide synthesis. Because T and B lymphocytes depend almost exclusively on this de novo pathway (unlike most other cells that can use the salvage pathway), MPA selectively suppresses lymphocyte proliferation while relatively sparing other rapidly dividing cells. This immunological selectivity provides effective immunosuppression with less myelotoxicity than azathioprine.
Avoid unless no suitable alternative; associated with congenital malformations and spontaneous abortions.
Manufacturer advises to avoid; present in milk in animal studies.
Drug interaction classified as: absorption
Source: DDInter
Drug interaction classified as: synergy.
Source: DDInter
Decreased plasma concentrations of mycophenolic acid, leading to reduced immunosuppressive effect and an increased risk of transplant rejection.
Monitor mycophenolic acid levels closely. Consider alternative antibiotic or increased mycophenolate dose. Monitor for signs of transplant rejection.
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: absorption
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: absorption
Source: DDInter
Drug interaction classified as: absorption
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, BNF·Verified: 2026-05-13 · House clinical team